Lipids abnormal
(UMLS:C0549634)
- UMLS ID:
- C0549634
- MeSH ID:
- N/A
Synonym(s)
1.
Lipids abnormal
2.
abnormalities lipid
3.
lipids abnormal
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Rosuvastatin Calcium | FAERS: 14 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 2 | rofecoxib | FAERS: 11 | US FAERS | |
| 3 | Olanzapine | FAERS: 9 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 4 | Simvastatin | FAERS: 7 | US FAERS | |
| 5 | Atorvastatin | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 6 | Isotretinoin | FAERS: 4 | US FAERS | |
| 7 | Clozapine | FAERS: 3 | OFFSIDES US FAERS | |
| 8 | Estrogens, Conjugated (USP) | FAERS: 3 | US FAERS | |
| 9 | Everolimus | FAERS: 3 | US FAERS | |
| 10 | Sertraline | FAERS: 3 | US FAERS | |
| 11 | tofacitinib | FAERS: 3 | US FAERS | |
| 12 | Aripiprazole | FAERS: 2 | US FAERS | |
| 13 | BMS201038 | FAERS: 2 | US FAERS | |
| 14 | Capecitabine | FAERS: 2 | OFFSIDES US FAERS | |
| 15 | Quetiapine Fumarate | FAERS: 2 | US FAERS | |
| 16 | Ranolazine | FAERS: 2 | US FAERS | |
| 17 | Risperidone | FAERS: 2 | US FAERS | |
| 18 | Simcor | FAERS: 2 | US FAERS | |
| 19 | 4-Aminopyridine | FAERS: 1 | US FAERS | |
| 20 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 1 | US FAERS | |
| 21 | AMG-416 | FAERS: 1 | US FAERS | |
| 22 | Acitretin | FAERS: 1 | US FAERS | |
| 23 | Atorvastatin | FAERS: 1 | OFFSIDES US FAERS | |
| 24 | Canagliflozin | FAERS: 1 | US FAERS | |
| 25 | Carvedilol | FAERS: 1 | US FAERS | |
| 26 | Dasatinib | FAERS: 1 | US FAERS | |
| 27 | Doxycycline | FAERS: 1 | US FAERS | |
| 28 | Ezetimibe | FAERS: 1 | US FAERS | |
| 29 | Finasteride | FAERS: 1 | US FAERS | |
| 30 | Goserelin | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 31 | LCZ 696 | FAERS: 1 | US FAERS | |
| 32 | Letrozole | FAERS: 1 | US FAERS | |
| 33 | Lopinavir | FAERS: 1 | OFFSIDES US FAERS | |
| 34 | Metformin | FAERS: 1 | US FAERS | |
| 35 | Mirtazapine | FAERS: 1 | US FAERS | |
| 36 | Mycophenolic Acid | FAERS: 1 | US FAERS | |
| 37 | Niacin | FAERS: 1 | OFFSIDES US FAERS | |
| 38 | NuvaRing | FAERS: 1 | US FAERS | |
| 39 | Omacor | FAERS: 1 | US FAERS | |
| 40 | Omeprazole | FAERS: 1 | US FAERS | |
| 41 | Orlistat | FAERS: 1 | US FAERS | |
| 42 | Pravastatin | FAERS: 1 | US FAERS | |
| 43 | Propofol | FAERS: 1 | US FAERS | |
| 44 | Rosuvastatin Calcium | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 45 | Sitagliptin Phosphate | FAERS: 1 | US FAERS | |
| 46 | Sofosbuvir | FAERS: 1 | US FAERS | |
| 47 | Thyroxine | FAERS: 1 | US FAERS | |
| 48 | Tiotropium Bromide | FAERS: 1 | US FAERS | |
| 49 | brexpiprazole | FAERS: 1 | US FAERS | |
| 50 | liposomal amphotericin B | FAERS: 1 | US FAERS | |
| 51 | obeticholic acid | FAERS: 1 | US FAERS | |
| 52 | Amoxapine | OFFSIDES | ||
| 53 | Atazanavir Sulfate | OFFSIDES | ||
| 54 | Azithromycin | OFFSIDES | ||
| 55 | Benztropine | OFFSIDES | ||
| 56 | Bisacodyl | OFFSIDES | ||
| 57 | Butorphanol | OFFSIDES | ||
| 58 | Calcium Compounds | OFFSIDES | ||
| 59 | Dapsone | OFFSIDES | ||
| 60 | Darunavir | OFFSIDES | ||
| 61 | Famotidine | OFFSIDES | ||
| 62 | Floxacillin | OFFSIDES | ||
| 63 | Fluoxetine | OFFSIDES | ||
| 64 | Indinavir | OFFSIDES | ||
| 65 | Methyltestosterone | OFFSIDES | ||
| 66 | Naproxen | OFFSIDES | ||
| 67 | Pramipexole | OFFSIDES | ||
| 68 | Prednisone | SIDER | ||
| 69 | Tenofovir | OFFSIDES | ||
| 70 | Tenofovir | OFFSIDES | ||
| 71 | Testosterone | SIDER | ||
| 72 | Tiotropium Bromide | OFFSIDES | ||
| 73 | Trazodone | OFFSIDES | ||
| 74 | Vitamin D | OFFSIDES | ||
| 75 | abacavir | OFFSIDES | ||
| 76 | aliskiren | OFFSIDES | ||
| 77 | butalbital | OFFSIDES | ||
| 78 | efavirenz | OFFSIDES |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.